{
    "clinical_study": {
        "@rank": "95695", 
        "acronym": "Ito-RCT1", 
        "arm_group": [
            {
                "arm_group_label": "Group A (intervention PIPC)", 
                "arm_group_type": "Experimental", 
                "description": "Patients in group A (intervention PIPC) were given AMP of 2g PIPC intravenously just after intubation. If the operation time was longer than 3 hours, additional infusion of same dose PIPC was done. After coming back to the patients' own room, one more infusion of same dose of same drug was done."
            }, 
            {
                "arm_group_label": "Group B (intervention CEZ)", 
                "arm_group_type": "Experimental", 
                "description": "Patients in Group B (intervention CEZ) were given AMP of 1g CEZ intravenously just after intubation. If the operation time was longer than 3 hours, additional infusion of same dose CEZ was done. After coming back to the patients' own room, one more infusion of same dose of same drug was done."
            }, 
            {
                "arm_group_label": "Group C (without AMP)", 
                "arm_group_type": "No Intervention", 
                "description": "Patients in Group C underwent surgery without any AMP."
            }
        ], 
        "brief_summary": {
            "textblock": "The effectiveness of antimicrobial prophylaxis (AMP) for prevention of surgical site\n      infection (SSI) following thyroid and parathyroid surgery remains uncertain. Present\n      prospective randomized control study (Ito-RCT1) assessed the effectiveness of AMP in clean\n      neck surgery associated with thyroid and parathyroid disease."
        }, 
        "brief_title": "Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery", 
        "completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Thyroid Disease", 
            "Parathyroid Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Parathyroid Diseases", 
                "Thyroid Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "Between November 2010 and April 2012, 2164 consecutive patients who agreed to attend the\n      randomized control study were enrolled. All the participants received surgery for thyroid\n      and parathyroid disease at Ito Hospital and randomized in three groups; Group A (n=541):\n      operation with AMP (PIPC, piperacillin sodium), Group B (n=541): operation with AMP (CEZ,\n      cefazolin sodium), and Group C (n=1082): operation without AMP.\n\n      Exclusion criteria\n\n        -  Patients who did not agree to attend the randomized control study.\n\n        -  Patients who received the operation including mediastinum with sternotomy.\n\n        -  Patients who received the operation including additional resection of trachea,\n           esophagus and larynx.\n\n        -  Patients who received the re-operation for post-operative bleedings.\n\n        -  Patients who had known allergy to cephem or penicillin."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Between November 2010 and April 2012, 2164 consecutive patients who agreed to attend\n             the randomized control study were enrolled. All the participants received surgery for\n             thyroid and parathyroid disease at Ito Hospital.\n\n        Exclusion Criteria:\n\n          -  Patients who did not agree to attend the randomized control study.\n\n          -  Patients who received the operation including mediastinum with sternotomy.\n\n          -  Patients who received the operation including additional resection of trachea,\n             esophagus and larynx.\n\n          -  Patients who received the re-operation for post-operative bleedings.\n\n          -  Patients who had known allergy to cephem or penicillin."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "10 Years"
        }, 
        "enrollment": {
            "#text": "2164", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01805856", 
            "org_study_id": "Ito-RCT1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group A (intervention PIPC)", 
                "intervention_name": "PIPC piperacillin sodium", 
                "intervention_type": "Drug", 
                "other_name": "PIPC, piperacillin sodium"
            }, 
            {
                "arm_group_label": "Group B (intervention CEZ)", 
                "intervention_name": "CEZ, cefazolin sodium", 
                "intervention_type": "Drug", 
                "other_name": "CEZ, cefazolin sodium"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Infective Agents", 
                "Cefazolin", 
                "Piperacillin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "antimicrobial prophylaxis", 
            "AMP", 
            "surgical site infection", 
            "SSI", 
            "thyroid", 
            "thyroidectomy", 
            "parathyroid", 
            "surgery"
        ], 
        "lastchanged_date": "March 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tokyo", 
                    "country": "Japan", 
                    "zip": "150-8308"
                }, 
                "name": "Ito Hospital"
            }
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "3", 
        "official_title": "Antimicrobial Prophylaxis for the Prevention of Surgical Site Infection in Thyroid and Parathyroid Surgery", 
        "other_outcome": {
            "description": "If the patients had a symptom of urinary tract infection, additional blood test and urine test were done to diagnose infection accurately.", 
            "measure": "Urinary tract infection after operation with or without antimicrobial prophylaxis", 
            "safety_issue": "No", 
            "time_frame": "1month after operation"
        }, 
        "overall_official": {
            "affiliation": "Ito Hospital", 
            "last_name": "Takashi Uruno, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Japan: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Surgical site infection was defined as patients who are necessary to receive the treatment such as surgical drainage or antibiotic medication. When the patients receive the surgical drainage, microbial culture was performed.", 
            "measure": "Surgical site infections after thyroid and parathyroid surgery", 
            "safety_issue": "No", 
            "time_frame": "1 month after operation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01805856"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The appearances of drug allergic reactions (skin rash and anaphylactic shock) were checked at operating room. Blood test to check up liver and renal dysfunction was done on the 3rd POD. Liver and renal dysfunction is clinically diagnosed by patients' own physicians and the author, and only counted the cases which function got worse compared to preoperative data.", 
            "measure": "Side effect of the drug for Antimicrobial prophylaxis", 
            "safety_issue": "Yes", 
            "time_frame": "4 days after operation"
        }, 
        "source": "Ito Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ito Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}